Spinal gene expression profiling and pathways analysis of a CB2 agonist (MDA7)-targeted prevention of paclitaxel-induced neuropathy

J. J. Xu, P. Diaz, B. Bie, F. Astruc-Diaz, J. Wu, H. Yang, D. L. Brown, M. Naguib

Research output: Contribution to journalArticlepeer-review

27 Scopus citations

Abstract

Aims: Patients receiving paclitaxel often develop peripheral neuropathies. We found that a novel selective cannabinoid CB2 receptor agonist (MDA7) prevents paclitaxel-induced mechanical allodynia in rats and mice. Here we investigated gene expression profiling in the lumbar spinal cord after 14-day treatment of MDA7 in paclitaxel animals and analyzed possible signaling pathways underlying the preventive effect of MDA7 on paclitaxel-induced neuropathy. Methods: Peripheral mechanical allodynia was induced in rats or mice receiving intraperitoneal (i.p.) injection of paclitaxel at a dose of 1. mg/kg daily for four consecutive days. MDA7 was administered at a dose of 15. mg/kg 15. min before paclitaxel and then continued daily for another 10. days. Whole-genome gene expression profiling in the lumbar spinal cord of MDA7 and paclitaxel-treated rats was investigated using microarray analysis. The Ingenuity pathway analysis was performed to determine the potential relevant canonical pathways responsible for the effect of MDA7 on paclitaxel-induced peripheral neuropathy. Results: We observed that the inflammatory molecular networks including tumor necrosis factor (TNF), nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB), transforming growth factor beta (TGFβ), and mitogen-activated protein kinases (MAPK) signaling are most relevant to the preventive effect of MDA7 on paclitaxel-induced peripheral neuropathy. In addition, genes encoding molecules that are important in central sensitization such as glutamate transporters and N-methyl-d-aspartate receptor 2B (NMDAR2B), and neuro-immune-related genes such as neuronal nitric oxide synthase (nNOS1), chemokine CX3CL1 (a mediator for microglial activation), toll-like receptor 2 (TLR2), and leptin were differentially modulated by MDA7. Conclusion: The preventive effect of MDA7 on paclitaxel-induced peripheral allodynia in rats may be associated with genes involved in signal pathways in central sensitization, microglial activation, and neuroinflammation in the spinal cord.

Original languageEnglish
Pages (from-to)185-194
Number of pages10
JournalNeuroscience
Volume260
DOIs
StatePublished - Feb 28 2014

Funding

This work was supported by start-up funds for M.N. and Grants from the office of Translational Research from MD Anderson Cancer Center.

FundersFunder number
University of Texas MD Anderson Cancer Center

    Keywords

    • Cannabinoid
    • Microglial activation
    • Neuroinflammation
    • Neuropathy
    • Paclitaxel

    Fingerprint

    Dive into the research topics of 'Spinal gene expression profiling and pathways analysis of a CB2 agonist (MDA7)-targeted prevention of paclitaxel-induced neuropathy'. Together they form a unique fingerprint.

    Cite this